Research Output per year
Research Output per year
Organisation profile
About us
The aim of CRIS is to build a world-leading multidisciplinary research center on inflamed skin diseases, in which clinical and basic scientists collaborate to study defined disease pathways, identify therapeutic targets, and translate these findings into clinical applications.
Click here to explore CRIS publications
Click here to explore grants and research projects at CRIS
CRIS focuses on seven key thematic areas of inflammatory skin diseases:
- Genetics and Systems Biology
- Immunomodulation
- Imaging
- Diagnostics
- Cell therapy
- Translation into clinical studies
- Drug development
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Center for Research on Inflammation of the Skin (CRIS) is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Ralf Ludwig
- Center for Research on Inflammation of the Skin (CRIS) - Group Leading Senior Scientist
- Center for Infectious and Inflammatory Diseases (ZIEL) - Group Leading Senior Scientist
- Institute of Experimental Dermatology - Group Leading Senior Scientist
Person: W3 Professor
-
Christian Sadik
- Center for Research on Inflammation of the Skin (CRIS) - Group Leading Senior Scientist
- Clinic of Dermatology, Allergology and Venerology - Professorship for Translantional Immunodermatology
- Center for Infectious and Inflammatory Diseases (ZIEL) - Group Leading Senior Scientist
Person: W3 Professor, W2 Professor
-
Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade
Pigors, M., Patzelt, S., Reichhelm, N., Dworschak, J., Khil'chenko, S., Emtenani, S., Bieber, K., Hofrichter, M., Kamaguchi, M., Goletz, S., Köhl, G., Köhl, J., Komorowski, L., Probst, C., Vanderheyden, K., Balbino, B., Ludwig, R. J., Verheesen, P. & Schmidt, E., 02.2024, In: Journal of Pathology. 262, 2, p. 161-174 14 p.Research output: Journal Articles › Journal articles › Research › peer-review
-
The Clinical Features of Hereditary Alpha-Tryptasemia—Implications for Interdisciplinary Practice
von Bubnoff, D., Koch, D., Stocker, H., Ludwig, R. J., Wortmann, F. & von Bubnoff, N., 19.04.2024, In: Deutsches Arzteblatt International. 121, 8, p. 258-264 7 p.Research output: Journal Articles › Scientific review articles › Research
-
A History of Asthma Increases the Risk of Bullous Pemphigoid: Insights from a Large Population-Based Study
Kridin, K., Ludwig, R. J., Tzur Bitan, D. & Cohen, A. D., 01.11.2021, In: Dermatology. 237, 6, p. 921-928 8 p.Research output: Journal Articles › Journal articles › Research › peer-review
-
CRC 1526, Project B10: Stromal regulation of inflammation in pemphigoid diseases
Hoffmann, M. (Principal Investigator (PI))
01.01.22 → …
Project: DFG Projects › DFG Joint Research: Collaborative Research Center/ Transregios
-
CRC 1526, Project B06: Targeting mitochondrial metabolism in pemphigoid diseases
Hirose, M. (Principal Investigator (PI)) & Vaeth, M. (Principal Investigator (PI))
01.01.22 → …
Project: DFG Projects › DFG Joint Research: Collaborative Research Center/ Transregios
-
Age-associated-susceptibility to B cell autoimmunity in murine epidermolysis bullosa acquisita
Manz, R. (Principal Investigator (PI))
01.01.22 → 31.12.26
Project: DFG Projects › DFG Individual Projects